Federal Register - March 19, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
14820
Federal Register / Vol. 86, No. 52 / Friday, March 19, 2021 / Rules and Regulations
34. In 522.995, revise paragraph b to read as follows:
522.995
Fluprostenol.
b Sponsor. See No. 058198 in 510.600c of this chapter.
35. In 522.1010, revise paragraph b3 to read as follows:
522.1010
Furosemide.
522.1696a Penicillin G benzathine and penicillin G procaine suspension.
Gonadorelin.
b
3 Nos. 000010 and 061133 for use of the 50-mg/mL product described in paragraph a3 of this section as in paragraphs e1i and v of this section.
37. In 522.1086, revise paragraph b to read as follows:
Guaifenesin solution.
b Sponsors. See Nos. 037990 and 058198 in 510.600c of this chapter.
38. In 522.1182, revise paragraph b1 introductory text to read as follows:
Iron injection.
Ivermectin and clorsulon.
jbell on DSKJLSW7X2PROD with RULES
e
3
i Nos. 000010, 055529, and 061133:
Do not treat cattle within 21 days of slaughter. No. 058005: Do not treat cattle within 49 days of slaughter.
40. In 522.1222, revise paragraph b to read as follows:
VerDate Sep<11>2014
16:22 Mar 18, 2021
Jkt 253001
522.1720
Phenylbutazone.
b
2 Nos. 000061, 054771, 058198, and 061133 for use of product described in paragraph a2 of this section as in paragraph c of this section.
44. In 522.1870, revise paragraph b to read as follows:
Praziquantel.
b
1 Nos. 016592 and 042552 for use of product described in paragraph a1i of this section as follows:
39. In 522.1193, revise paragraph e3i to read as follows:
d
2
iii Limitations. Not for use within 30
days of slaughter. For Nos. 000859 and 016592: A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal.
43. In 522.1720, revise paragraph b2 to read as follows:
522.1870
522.1193
Moxidectin solution.
b Sponsor. See No. 058198 in 510.600c of this chapter.
42. In 522.1696a, revise paragraph d2iii to read as follows:
522.1182
b Sponsors. See Nos. 017033, 054771, 058198, 059399, 063286, and 069043 in 510.600c of this chapter.
41. In 522.1450, revise paragraph b to read as follows:
b
3 No. 058198 as described in paragraph a2 of this section for use as in paragraphs d1, d2i, and d3 of this section.
36. In 522.1077:
a. Revise paragraph b3;
b. Remove paragraph b4; and c. Redesignate paragraph b5 as paragraph b4.
The revision reads as follows:
522.1086
Ketamine.
522.1450
522.1077
522.1222
b Sponsors. See Nos. 058198 and 061133 in 510.600c of this chapter.
45. In 522.1890, revise the section heading to read as follows:
522.1890
Prednisone suspension.
d Conditions of use. It is administered as follows:
1 Turkeys 1- to 3-day-old poults and chickens newly hatched chicks i Amounts and indications for use. A
Administer 5 mg per poult subcutaneously as an aid in the control of chronic respiratory disease CRD
associated with Escherichia coli in 1- to 3-day-old turkey poults.
B Administer 10 mg per poult as a single subcutaneous injection in the nape of the neck as an aid in the control of airsacculitis associated with Mycoplasma meleagridis sensitive to spectinomycin in 1- to 3-day-old turkey poults.
C Administer 2.5 to 5 mg per chick as an aid in the control of mortality and to lessen severity of infections caused by M. synoviae, Salmonella typhimurium, S. infantis, and E. coli.
ii Limitations. For use only in 1- to 3-day-old turkey poults and newly hatched chicks.
2 Dogsi Amount. Administer 2.5
to 5.0 mg per pound of body weight by intramuscular injection twice daily.
Treatment may be continued for 4 days.
ii Indications for use. For treatment of infections caused by gram-negative and gram-positive organisms susceptible to spectinomycin.
iii Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
47. In 522.2662, revise paragraph b3 to read as follows:
522.2662
Xylazine.
b
3 Nos. 058198 and 061651 for use of product described in paragraph a1 of this section as in paragraph d1 of this section; and product described in paragraph a2 of this section as in paragraphs d2, d3i, d3iiA, and d3iii of this section.
46. Revise 522.2120 to read as follows:
PART 524OPHTHALMIC AND
TOPICAL DOSAGE FORM NEW
ANIMAL DRUGS
522.2120
Spectinomycin hydrochloride.
a Specifications. Each milliliter of solution contains 100 milligrams mg spectinomycin hydrochloride as spectinomycin dihydrochloride pentahydrate.
b Sponsors. See sponsors in 510.600c of this chapter:
1 Nos. 016592 and 054771 for use as in paragraph d1 of this section; and 2 No. 058198 for use as in paragraph d2 of this section.
c Related tolerances. See 556.600
of this chapter.
PO 00000
Frm 00014
Fmt 4700
Sfmt 4700
48. The authority citation for part 524
continues to read as follows:
Authority: 21 U.S.C. 360b.
49. In 524.450, revise paragraph b to read as follows:
524.450
Clotrimazole.
b Sponsor. See No. 058198 in 510.600c of this chapter.
50. In 524.775, revise paragraph b to read as follows:
E:FRFM19MRR1.SGM
19MRR1
